First Time Loading...
P

PCC Rokita SA
WSE:PCR

Watchlist Manager
PCC Rokita SA
WSE:PCR
Watchlist
Price: 94.4 PLN -4.65% Market Closed
Updated: May 17, 2024

Intrinsic Value

PCC Rokita SA engages in the sale and production of chemical products. [ Read More ]

The intrinsic value of one PCR stock under the Base Case scenario is 88.62 PLN. Compared to the current market price of 94.4 PLN, PCC Rokita SA is Overvalued by 6%.

Key Points:
PCR Intrinsic Value
Base Case
88.62 PLN
Overvaluation 6%
Intrinsic Value
Price
P
Worst Case
Base Case
Best Case

Valuation Backtest
PCC Rokita SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PCR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
PCC Rokita SA

Provide an overview of the primary business activities
of PCC Rokita SA.

What unique competitive advantages
does PCC Rokita SA hold over its rivals?

What risks and challenges
does PCC Rokita SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for PCC Rokita SA.

Provide P/S
for PCC Rokita SA.

Provide P/E
for PCC Rokita SA.

Provide P/OCF
for PCC Rokita SA.

Provide P/FCFE
for PCC Rokita SA.

Provide P/B
for PCC Rokita SA.

Provide EV/S
for PCC Rokita SA.

Provide EV/GP
for PCC Rokita SA.

Provide EV/EBITDA
for PCC Rokita SA.

Provide EV/EBIT
for PCC Rokita SA.

Provide EV/OCF
for PCC Rokita SA.

Provide EV/FCFF
for PCC Rokita SA.

Provide EV/IC
for PCC Rokita SA.

Show me price targets
for PCC Rokita SA made by professional analysts.

What are the Revenue projections
for PCC Rokita SA?

How accurate were the past Revenue estimates
for PCC Rokita SA?

What are the Net Income projections
for PCC Rokita SA?

How accurate were the past Net Income estimates
for PCC Rokita SA?

What are the EPS projections
for PCC Rokita SA?

How accurate were the past EPS estimates
for PCC Rokita SA?

What are the EBIT projections
for PCC Rokita SA?

How accurate were the past EBIT estimates
for PCC Rokita SA?

Compare the revenue forecasts
for PCC Rokita SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of PCC Rokita SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of PCC Rokita SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of PCC Rokita SA compared to its peers.

Compare the P/E ratios
of PCC Rokita SA against its peers.

Discuss the investment returns and shareholder value creation
comparing PCC Rokita SA with its peers.

Analyze the financial leverage
of PCC Rokita SA compared to its main competitors.

Show all profitability ratios
for PCC Rokita SA.

Provide ROE
for PCC Rokita SA.

Provide ROA
for PCC Rokita SA.

Provide ROIC
for PCC Rokita SA.

Provide ROCE
for PCC Rokita SA.

Provide Gross Margin
for PCC Rokita SA.

Provide Operating Margin
for PCC Rokita SA.

Provide Net Margin
for PCC Rokita SA.

Provide FCF Margin
for PCC Rokita SA.

Show all solvency ratios
for PCC Rokita SA.

Provide D/E Ratio
for PCC Rokita SA.

Provide D/A Ratio
for PCC Rokita SA.

Provide Interest Coverage Ratio
for PCC Rokita SA.

Provide Altman Z-Score Ratio
for PCC Rokita SA.

Provide Quick Ratio
for PCC Rokita SA.

Provide Current Ratio
for PCC Rokita SA.

Provide Cash Ratio
for PCC Rokita SA.

What is the historical Revenue growth
over the last 5 years for PCC Rokita SA?

What is the historical Net Income growth
over the last 5 years for PCC Rokita SA?

What is the current Free Cash Flow
of PCC Rokita SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for PCC Rokita SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
PCC Rokita SA

Current Assets 797.2m
Cash & Short-Term Investments 290m
Receivables 324.6m
Other Current Assets 182.5m
Non-Current Assets 1.7B
PP&E 1.5B
Intangibles 112.9m
Other Non-Current Assets 65.5m
Current Liabilities 502.2m
Accounts Payable 191.3m
Accrued Liabilities 63.9m
Short-Term Debt 8.1m
Other Current Liabilities 238.9m
Non-Current Liabilities 641.4m
Long-Term Debt 492.8m
Other Non-Current Liabilities 148.6m
Efficiency

Earnings Waterfall
PCC Rokita SA

Revenue
2.4B PLN
Cost of Revenue
-1.8B PLN
Gross Profit
584.3m PLN
Operating Expenses
-227.6m PLN
Operating Income
356.7m PLN
Other Expenses
-88.9m PLN
Net Income
267.8m PLN

Free Cash Flow Analysis
PCC Rokita SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

PCR Profitability Score
Profitability Due Diligence

PCC Rokita SA's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Free Cash Flow
Positive 3-Year Average ROIC
Positive Gross Profit
64/100
Profitability
Score

PCC Rokita SA's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

PCR Solvency Score
Solvency Due Diligence

PCC Rokita SA's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
High Altman Z-Score
Short-Term Solvency
61/100
Solvency
Score

PCC Rokita SA's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PCR Price Targets Summary
PCC Rokita SA

Wall Street analysts forecast PCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PCR is 102.82 PLN with a low forecast of 101.81 PLN and a high forecast of 105.84 PLN.

Lowest
Price Target
101.81 PLN
8% Upside
Average
Price Target
102.82 PLN
9% Upside
Highest
Price Target
105.84 PLN
12% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
PCC Rokita SA

Shareholder Return

PCR Price
PCC Rokita SA

1M 1M
-6%
6M 6M
+5%
1Y 1Y
-9%
3Y 3Y
+59%
5Y 5Y
+57%
10Y 10Y
+457%
Annual Price Range
94.4
52w Low
83.2
52w High
112
Price Metrics
Average Annual Return 20.69%
Standard Deviation of Annual Returns 49.44%
Max Drawdown -62%
Shares Statistics
Market Capitalization 1.9B PLN
Shares Outstanding 19 853 300
Percentage of Shares Shorted
N/A

PCR Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

PCC Rokita SA

Country

Poland

Industry

Chemicals

Market Cap

1.9B PLN

Dividend Yield

0%

Description

PCC Rokita SA engages in the sale and production of chemical products. The company is headquartered in Brzeg Dolny, Woj. Dolnoslaskie and currently employs 1,791 full-time employees. The company went IPO on 2014-06-25. The company divides its business into three segments: Chemicals that includes manufacture of such products as polyols, comprising polyether polyols for the production of polyurethane polymers, among others; chloralkali, including chlorine and soda lye; chlorobenzene, such as monochlorobenzene, dichlorobenzene and technical hydrochloric acid; phosphorus derivates; and naphthalene derivates; Energy engaged in the production and distribution of electric and thermal energy, demineralized water and compressed air; and Other Activities composed of assembly and maintenance of industrial armature, technical monitoring and consulting services, waste management, among others.

Contact

WOJ. DOLNOSLASKIE
Brzeg Dolny
ul. Sienkiewicza 4
+48717942000
https://pcc.rokita.pl/

IPO

2014-06-25

Employees

1 791

Officers

President of the Management & General Director
Mr. Wieslaw Klimkowski
Vice Chairman of the Management Board & Financial Director
Mr. Rafal Zdon
Secretary of the Supervisory Board & Independent Member of Supervisory Board
Mr. Robert Pabich
Chief Accountant, Director of the Accounting Office CWB & Member of Management Board
Beata Dobecka

See Also

Discover More
What is the Intrinsic Value of one PCR stock?

The intrinsic value of one PCR stock under the Base Case scenario is 88.62 PLN.

Is PCR stock undervalued or overvalued?

Compared to the current market price of 94.4 PLN, PCC Rokita SA is Overvalued by 6%.